Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms

NCT05000892 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Salivary Gland Malignant Neoplasms
Salivary Gland Tumors

Interventions

DRUG: Sintilimab , Carboplatin, Nab-paclitaxel

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University